TRANSGENE SA (TNG.PA) Stock Fundamental Analysis

EPA:TNG • FR0005175080

0.822 EUR
+0.01 (+1.48%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

1

TNG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 78 industry peers in the Biotechnology industry. Both the profitability and financial health of TNG have multiple concerns. TNG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • TNG had negative earnings in the past year.
  • In the past year TNG has reported a negative cash flow from operations.
  • TNG had negative earnings in each of the past 5 years.
  • In the past 5 years TNG always reported negative operating cash flow.
TNG.PA Yearly Net Income VS EBIT VS OCF VS FCFTNG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • TNG has a Return On Assets of -82.88%. This is in the lower half of the industry: TNG underperforms 70.51% of its industry peers.
Industry RankSector Rank
ROA -82.88%
ROE N/A
ROIC N/A
ROA(3y)-59.77%
ROA(5y)-43.73%
ROE(3y)-151.05%
ROE(5y)-103.3%
ROIC(3y)N/A
ROIC(5y)N/A
TNG.PA Yearly ROA, ROE, ROICTNG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • TNG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TNG.PA Yearly Profit, Operating, Gross MarginsTNG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • TNG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TNG has been increased compared to 1 year ago.
  • TNG has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, TNG has an improved debt to assets ratio.
TNG.PA Yearly Shares OutstandingTNG.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TNG.PA Yearly Total Debt VS Total AssetsTNG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • TNG has an Altman-Z score of -2.27. This is a bad value and indicates that TNG is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -2.27, TNG is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.27
ROIC/WACCN/A
WACC7.94%
TNG.PA Yearly LT Debt VS Equity VS FCFTNG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.54 indicates that TNG may have some problems paying its short term obligations.
  • The Current ratio of TNG (0.54) is worse than 82.05% of its industry peers.
  • TNG has a Quick Ratio of 0.54. This is a bad value and indicates that TNG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of TNG (0.54) is worse than 79.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
TNG.PA Yearly Current Assets VS Current LiabilitesTNG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for TNG have decreased strongly by -31.17% in the last year.
  • The Revenue for TNG has decreased by -20.34% in the past year. This is quite bad
  • The Revenue for TNG have been decreasing by -14.48% on average. This is quite bad
EPS 1Y (TTM)-31.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.84%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y-29.03%
Revenue growth 5Y-14.48%
Sales Q2Q%36.11%

3.2 Future

  • Based on estimates for the next years, TNG will show a decrease in Earnings Per Share. The EPS will decrease by -1.42% on average per year.
  • TNG is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 29.60% yearly.
EPS Next Y55.56%
EPS Next 2Y21.72%
EPS Next 3Y8.51%
EPS Next 5Y-1.42%
Revenue Next Year4.56%
Revenue Next 2Y7.16%
Revenue Next 3Y12.55%
Revenue Next 5Y29.6%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TNG.PA Yearly Revenue VS EstimatesTNG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
TNG.PA Yearly EPS VS EstimatesTNG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TNG. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TNG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNG.PA Price Earnings VS Forward Price EarningsTNG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNG.PA Per share dataTNG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.72%
EPS Next 3Y8.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TNG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRANSGENE SA

EPA:TNG (2/20/2026, 7:00:00 PM)

0.822

+0.01 (+1.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04
Earnings (Next)03-24
Inst Owners0.32%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap225.38M
Revenue(TTM)6.08M
Net Income(TTM)-33.97M
Analysts82.86
Price Target1.38 (67.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.96%
PT rev (3m)-32.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)59.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)52.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 37.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.02
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -82.88%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-59.77%
ROA(5y)-43.73%
ROE(3y)-151.05%
ROE(5y)-103.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 100.97%
Cap/Sales 22.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z -2.27
F-Score2
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)165.93%
Cap/Depr(5y)113.96%
Cap/Sales(3y)33.44%
Cap/Sales(5y)22.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.84%
EPS Next Y55.56%
EPS Next 2Y21.72%
EPS Next 3Y8.51%
EPS Next 5Y-1.42%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y-29.03%
Revenue growth 5Y-14.48%
Sales Q2Q%36.11%
Revenue Next Year4.56%
Revenue Next 2Y7.16%
Revenue Next 3Y12.55%
Revenue Next 5Y29.6%
EBIT growth 1Y-18.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.42%
EBIT Next 3Y-22.93%
EBIT Next 5YN/A
FCF growth 1Y31.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.14%
OCF growth 3YN/A
OCF growth 5YN/A

TRANSGENE SA / TNG.PA FAQ

What is the ChartMill fundamental rating of TRANSGENE SA (TNG.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to TNG.PA.


What is the valuation status of TRANSGENE SA (TNG.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to TRANSGENE SA (TNG.PA). This can be considered as Overvalued.


Can you provide the profitability details for TRANSGENE SA?

TRANSGENE SA (TNG.PA) has a profitability rating of 0 / 10.


What is the earnings growth outlook for TRANSGENE SA?

The Earnings per Share (EPS) of TRANSGENE SA (TNG.PA) is expected to grow by 55.56% in the next year.